SURVEYOR-I: 98% - 100% SVR4 in HCV Genotype 1 Non-Cirrhotic Treatment-Naïve or Pegylated Interferon/Ribavirin Null-Responders with the Combination of the Next Generation NS3/4A Protease Inhibitor ABT-493 and NS5A Inhibitor ABT-530

Press/Media: Press / Media

PeriodNov 17 2015

Media coverage

1

Media coverage

  • TitleSURVEYOR-I: 98% - 100% SVR4 in HCV Genotype 1 Non-Cirrhotic Treatment-Naïve or Pegylated Interferon/Ribavirin Null-Responders with the Combination of the Next Generation NS3/4A Protease Inhibitor ABT-493 and NS5A Inhibitor ABT-530
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date11/17/15
    PersonsFred Poordad
View all 1
View less